EFFICACY OF VONOPRAZAN 10 MG AND 20 MG FOR PATIENTS WITH PROTON PUMP INHIBITORS (PPI)-REFRACTORY FUNCTIONAL DYSPEPSIA (FD): A DOUBLE-BLINDED, RANDOMIZED STUDY

被引：0
|
作者：
Bunchorntavakul, Chalermra
Jaigla, Pantaree
Sribuathong, Nattida
机构：
来源：
GASTROENTEROLOGY | 2024年 / 166卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Su1634
引用
收藏
页码：S775 / S775
页数：1
相关论文
共 50 条
  • [1] Efficacy of Vonoprazan 10 mg and 20 mg for Patients With Proton Pump Inhibitor-Refractory Functional Dyspepsia: A Double-Blinded, Randomized Study
    Bunchorntavakul, Chalermrat
    Jaigla, Pantaree
    JGH OPEN, 2024, 8 (12):
  • [2] COMPARABLE EFFICACY OF CURCUMIN AND PROTON PUMP INHIBITOR FOR FUNCTIONAL DYSPEPSIA: A RANDOMIZED DOUBLE-BLINDED CONTROLLED TRIAL
    Khongkha, Wichittra
    Kongkam, Pradermchai
    Pongpirul, Krit
    Kosarussawadee, Prach
    Phutrakool, Phanupong
    Khamsai, Sittichai
    Sawanyawisuth, Kittisak
    Sura, Thanyachai
    Phisalprapa, Pochamana
    Buamahahkul, Thanwa
    Siwamogsatham, Sarawut
    Wanaratna, Kulthanit
    Angsusing, Jaenjira
    Teerachaisakul, Monthaka
    GUT, 2021, 70 : A100 - A101
  • [3] EFFICACY OF VONOPRAZAN IN PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE: A RANDOMIZED COMPARATIVE STUDY OF 20MG AND 10MG.
    Okanobu, Hideharu
    Kohno, Tomohiko
    Mouri, Ritsuo
    Miyaki, Eisuke
    Fukuhara, Takayuki
    Okazaki, Akihito
    Takaki, Shintaro
    Mori, Nami
    Tsuji, Keiji
    Furukawa, Yoshinari
    GASTROENTEROLOGY, 2020, 158 (06) : S1056 - S1056
  • [4] Efficacy of vonoprazan 10 mg compared with 20 mg for the initial treatment in patients with erosive esophagitis: a randomized pilot study
    Hideharu Okanobu
    Tomohiko Kohno
    Ritsuo Mouri
    Yoshiki Hatsushika
    Yumiko Yamashita
    Eisuke Miyaki
    Takayuki Fukuhara
    Akihito Okazaki
    Ayaka Sakano
    Ayako Urabe
    Shintaro Takaki
    Nami Mori
    Keiji Tsuji
    Hidenori Ochi
    Yoshinari Furukawa
    Esophagus, 2021, 18 : 669 - 675
  • [5] Efficacy of vonoprazan 10 mg compared with 20 mg for the initial treatment in patients with erosive esophagitis: a randomized pilot study
    Okanobu, Hideharu
    Kohno, Tomohiko
    Mouri, Ritsuo
    Hatsushika, Yoshiki
    Yamashita, Yumiko
    Miyaki, Eisuke
    Fukuhara, Takayuki
    Okazaki, Akihito
    Sakano, Ayaka
    Urabe, Ayako
    Takaki, Shintaro
    Mori, Nami
    Tsuji, Keiji
    Ochi, Hidenori
    Furukawa, Yoshinari
    ESOPHAGUS, 2021, 18 (03) : 669 - 675
  • [6] Evidence That Proton Pump Inhibitors (PPIs) Decrease Duodenal Eosinophils - An Explanation for Efficacy of PPI Treatment in Functional Dyspepsia (FD)?
    Wood, Nicola
    Walker, Marjorie M.
    Jones, Michael P.
    Talley, Nicholas J.
    GASTROENTEROLOGY, 2015, 148 (04) : S822 - S823
  • [7] Safety and Efficacy of Ferula asafoetida in Functional Dyspepsia: A Randomized, Double-Blinded, Placebo-Controlled Study
    Mala, K. N.
    Thomas, Jestin
    Syam, Das S.
    Maliakel, Balu
    Krishnakumar, I. M.
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2018, 2018
  • [8] Abnormal Esophageal pH Study As Predictor of Treatment Response to Proton Pump Inhibitor (PPI) in Patients with Functional Dyspepsia (FD)
    Wu, Justin
    Cheong, Pui Kuan
    Chan, Yawen
    Lee, Sau Fong E.
    Lai, Larry
    Sung, Joseph J.
    Chan, Francis K. L.
    GASTROENTEROLOGY, 2009, 136 (05) : A148 - A149
  • [9] A randomized, double-blind study to evaluate the acid-inhibitory effect of vonoprazan (20 mg and 40 mg) in patients with proton-pump inhibitor-resistant erosive esophagitis
    Iwakiri, Katsuhiko
    Sakurai, Yuuichi
    Shiino, Madoka
    Okamoto, Hiroyuki
    Kudou, Kentaro
    Nishimura, Akira
    Hiramatsu, Naoki
    Umegaki, Eiji
    Ashida, Kiyoshi
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2017, 10 (06): : 439 - 451
  • [10] A comparison of the effects of d-003 and policosanol (5 and 10 mg/d) in patients with type h hypercholesterolemia: a randomized, double-blinded study A comparison of the effects of d-003 and policosanol (5 and 10 mg/d) in patients with type h hypercholesterolemia: a randomized, double-blinded study
    不详
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 565 - 565
12345